Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hepion Pharmaceuticals Inc

HEPA
Current price
1.15 USD +0.05 USD (+4.55%)
Last closed 1.12 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 6 129 358 USD
Yield for 12 month -89.24 %
1Y
3Y
5Y
10Y
15Y
HEPA
21.11.2021 - 28.11.2021

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

26 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+109 730 USD

Last Quarter

Current Year

-67 131 USD

Last Year

-77 461 USD

Current Quarter

+97 465 USD

Last Quarter

Key Figures HEPA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -37 151 256 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -71.07 %
PEG Ratio
Return On Equity TTM -172.45 %
Wall Street Target Price 26 USD
Revenue TTM
Book Value 1.07 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -9.4 USD
Diluted Eps TTM -9.4 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics HEPA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HEPA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 11.05.2023
Dividend Date 03.06.2019

Stock Valuation HEPA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1542
Price Book MRQ 0.6748

Financials HEPA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HEPA

For 52 weeks

1.06 USD 12.88 USD
50 Day MA 1.8 USD
Shares Short Prior Month 63 892
200 Day MA 3.38 USD
Short Ratio 0.61
Shares Short 32 828
Short Percent 0.6 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics